(Q35795345)

10 August 2017

1 reference

title

The evaluation and management of dyslipidemia and impaired glucose metabolism during acute coronary syndromes (English)

1 reference

10 August 2017

1 reference

acute coronary syndrome

1 reference

3

Kenneth W Mahaffey

1 reference

10 August 2017

Abhinav Goyal

1

1 reference

10 August 2017

John L Petersen

series ordinal

2

1 reference

10 August 2017

publication date

1 July 2004

1 reference

Current cardiology reports

10 August 2017

published in

1 reference

10 August 2017

volume

6

1 reference

10 August 2017

issue

4

1 reference

10 August 2017

page(s)

300-307

1 reference

Impact of Diabetes on Long-Term Prognosis in Patients With Unstable Angina and Non–Q-Wave Myocardial Infarction

10 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11886-004-0080-1

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

12 December 2020

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

12 December 2020

Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban

1 reference

12 December 2020

Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials

1 reference

12 December 2020

Variations in lipoprotein levels after myocardial infarction and unstable angina: the LATIN trial

1 reference

12 December 2020

A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes

1 reference

12 December 2020

Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study

1 reference

12 December 2020

Usefulness of lipoprotein changes during acute coronary syndromes for predicting postdischarge lipoprotein levels

1 reference

12 December 2020

Measurement of plasma lipids in patients admitted with acute myocardial infarction or unstable angina pectoris

1 reference

12 December 2020

Early statin initiation and outcomes in patients with acute coronary syndromes

1 reference

12 December 2020

Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.

1 reference

12 December 2020

Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial

1 reference

12 December 2020

1999 update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Comm

1 reference

12 December 2020

Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study

1 reference

12 December 2020

Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group

1 reference

12 December 2020

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

1 reference

12 December 2020

The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994.

1 reference

12 December 2020

Withdrawal of statins increases event rates in patients with acute coronary syndromes

1 reference

12 December 2020

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1 reference

12 December 2020

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

12 December 2020

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

12 December 2020

Short-term mortality of myocardial infarction patients with diabetes or hyperglycaemia during admission

1 reference

12 December 2020

Myocardial infarction and prevalence of diabetes mellitus. Is increased casual blood glucose at admission a reliable criterion for the diagnosis of diabetes?

1 reference

12 December 2020

Prognosis of medically stabilized unstable angina pectoris with a negative exercise test

1 reference

12 December 2020

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

12 December 2020

ACC/AHA Guideline Update for the Management of Patients With Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction--2002: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice G

1 reference

12 December 2020

Intensive insulin therapy in critically ill patients

1 reference

12 December 2020

Glucose-insulin-potassium in acute myocardial infarction: the time has come for a large, prospective trial

1 reference

12 December 2020

The A-to-Z Trial: Methods and rationale for a single trial investigating combined use of low-molecular-weight heparin with the glycoprotein IIb/IIIa inhibitor tirofiban and defining the efficacy of early aggressive simvastatin therapy

1 reference

12 December 2020

Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators

1 reference

12 December 2020

Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year

1 reference

12 December 2020

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group

1 reference

12 December 2020

Benefits of statin therapy in patients with special risks: Coronary bypass surgery, stable coronary disease, and acute coronary syndromes

1 reference

12 December 2020

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

1 reference

12 December 2020

Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiológicos Latinoamérica) Collaborative Group

1 reference

12 December 2020

Low-dose glucose-insulin-potassium is ineffective in acute myocardial infarction: results of a randomized multicenter Pol-GIK trial

1 reference

12 December 2020

Polarizing solution in Myocardial Infarction

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Early statin treatment following acute myocardial infarction and 1-year survival

1 reference

12 December 2020

Withdrawal of statins in patients with acute coronary syndromes

1 reference

12 December 2020

Reduction of hospital mortality rate of acute myocardial infarction with glucose-insulin-potassium infusion

1 reference

12 December 2020

The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina

1 reference

12 December 2020

Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era?

1 reference

12 December 2020

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

1 reference

12 December 2020

10.1007/S11886-004-0080-1

Identifiers

DOI

1 reference

10 August 2017

1 reference